Investor Relations Disclaimer

You are about to review video/audio content from Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) that contains time-sensitive information. The information contained therein is only current as of the date thereof. Aldeyra expressly disclaims any obligation to review, update or correct these materials after the date thereof. Aldeyra may update, amend, supplement or otherwise alter the information contained in any such materials by subsequent presentations, reports, filings, or other means without notice.

Certain statements made on this web site or in materials accessed in or through this section of our web site are “forward-looking statements,” which are subject to risks and uncertainties, and Aldeyra’s actual results may differ materially from those statements. Please see our SEC filings, including our most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q, for a detailed list of risk factors.

Understand

Safe Harbor Disclosure

This video content contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding Aldeyra’s possible or assumed future results of operations, expenses and financing needs, business strategies and plans, research and development plans or expectations, trends, the structure, timing and success of Aldeyra’s planned or pending clinical trials, expected milestones, market sizing, pricing and reimbursement, competitive position, regulatory matters, industry environment and potential growth opportunities, among other things. Actual results or trends could differ materially from those contemplated by these forward-looking statements. For more information, please refer to the risk factors discussed in Aldeyra's periodic filings with the SEC, including the most recent Form 10-Q or 10-K. Any forward-looking statements that are made in the video content are based on assumptions as of the original date of the creation of such video, and Aldeyra undertakes no obligation to update these statements as a result of new information or future events.

Continue to video